Hirohiko Hanaki
Director, Chief Compliance Officer (CCO) & Head of Regenerative Medicine Business Division @ CellSource
Hirohiko Hanaki is a startup investor at CellSource. Born in 1969, he was born in Aichi Prefecture. Graduated from Gifu University, Faculty of Agriculture in 1991. In the same year, he joined Nidec Co., Ltd., a manufacturer of ophthalmology and medical devices. After working in development as a programmer, he was responsible for the pharmaceutical license of medical devices. In 2005, he transferredto Japan Tissue Engineering Co., Ltd., which develops regenerative medicine related business, and was engaged in the Pharmaceutical Affairs Department as a safety management officer after manufacturing and sales of regenerative medical products. In 2014, the Enforcement of the Safety Ensuring Act for Regenerative Medicine and the Revision of the Pharmaceutical Affairs Act will be in charge of consulting for medical institutions in compliance with these regulations. Later, he participated in the establishment of CellSource's regenerative medical center in 2016 as an expert in pharmaceutical business and regenerative medical laws. Currently, as Director and Director of CCO Regenerative Medicine Division, he also focuses on the enlightenment of the safety of regenerative medicine through his work.
Last updated:
For AI agents: llms.txt
About CellSource
CellSource provides adipose-derived stem cell processing services, blood-derived processing contract services, and support services for compliance with laws and regulations in areas such as regenerative medicine.
CellSource Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hideo Koyama
Auditor
|
|||
|
Hirohiko Hanaki
Director, Chief Compliance Officer (CCO) & Head of Regenerative Medicine Business Division
|
|||
|
Kaneshima Hideto
Chief Technical Advisor & Doctor of Medicine
|
|||
Kenta Fujita
Executive Officer
|
|||
Masahiro Samejima
General Counsel and Patent Attorney
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
